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Abstract: Injectable hydrogels with tunable physiochemical and biological 
properties are potential tools for improving neural stem/progenitor cell 
(NSPC) transplantation to treat central nervous system (CNS) injury and 
disease. Here, we developed injectable diblock copolypeptide hydrogels 
(DCH) for NSPC transplantation that contain hydrophilic segments of 
modified L-methionine (Met). Multiple Met-based DCH were fabricated by 
post-polymerization modification of Met to various functional 
derivatives, and incorporation of different amino acid comonomers into 
hydrophilic segments. Met-based DCH assembled into self-healing hydrogels 
with concentration and composition dependent mechanical properties. 
Mechanical properties of non-ionic Met-sulfoxide formulations (DCHMO) 
were stable across diverse aqueous media while cationic formulations 
showed salt ion dependent stiffness reduction. Murine NSPC survival in 
DCHMO was equivalent to that of standard culture conditions, and 
sulfoxide functionality imparted cell non-fouling character. Within serum 
rich environments in vitro, DCHMO was superior at preserving NSPC 
stemness and multipotency compared to cell adhesive materials. NSPC in 
DCHMO injected into uninjured forebrain remained local and, after 4 
weeks, exhibited an immature astroglial phenotype that integrated with 
host neural tissue and acted as cellular substrates that supported growth 
of host-derived axons. These findings demonstrate that Met-based DCH are 
suitable vehicles for further study of NSPC transplantation in CNS injury 
and disease models. 
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Responses to Reviewer Comments: Ms. No. jbmt43815.  
 
Responses given in blue and italics. 
 
Reviewer #3:  
This manuscript developed a new injectable modified L-methionine (Met) based 
diblock copolypeptide hydrogels (DCH) amenable to NSPC transplantation. The 
findings are novel and interesting. It's publishable.    
 
We appreciate the reviewer’s positive comments about our manuscript.  
 
 
Reviewer #4:  
In this study, the authors use injectable diblock copolypeptide hydrogels (DCH) 
for neural stem/progenitor cell (NSPC) transplantation. Although this idea and 
strategy is not new, the application of this paper work aims at central nervous 
system injury and disease are interesting.  
 
Although the reviewer states that the idea and strategy is not new, we would like 
to point out that design and preparation of the DCH in this manuscript are new, 
and introduce a practical, efficient means to tune biomaterial hydrogel properties 
via a variety of different methionine modifications, which is unprecedented. Also, 
this manuscript introduces a new passagable NSPC line not previously described 
that contains transgenically inserted Ribotag functionality. The Ribotag transgene 
provides a transplant cell identification marker on histology (as demonstrated 
here) as well as the capacity to precipitate translating mRNA of only grafted cells 
from whole tissue in future studies. We affirm that these cells will be an important 
tool for us and others in the CNS grafting field moving forward and this 
manuscript serves an important first evaluation of their potential.  
 
Some concerns and critical issues are listed below for the quality improvement of 
this paper manuscript.   
 
1. From the data of Scheme 1, it seems like that the synthesized MA 
copolymer can become gelation only in very low M/A ratio (M:A=97.5:2.5). This 
may greatly limit its further biomedical applications.     
 
As noted in the rationale given in the text on p.17-18, gelation in the synthesis of 
MA copolymers was not desired because it interferes with the ability to prepare 
diblock copolypeptides, and so we focused attention on the MA segment 
compositions that did not form gels in the organic solvent reaction mixture. 
Hence, the narrow window for organogel formation seen for MA compositions 
was not at all limiting in our subsequent preparation of hydrogels. Please note 
that there was no intention, or mention anywhere in the text, that these organogel 
reaction mixtures should be used in biomedical applications. This experiment 
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was used only as part of the optimization of copolypeptide synthesis en route to 
hydrogel preparation. 
 
2. As shown in Scheme 2, there 's a Ala in the backbone chemical 
structure of modified methionine amphiphilic diblock copolypeptides. Please 
specify the reason in the manuscript.    
 
The incorporation of Ala residues in the modified methionine segments was used 
to facilitate synthesis of the copolypeptides, and the rationale for Ala 
incorporation, and its (negligible) effect on resulting modified methionine 
copolypeptide properties, was described in detail in the text on p.17-18.  
 
3. From Fig. 1A and Fig. 2A, it is not understandable why the rheological 
property of DCHMO hold the highest storage modulus in the condition of L28 and 
then drop down, while DCHMM show different pattern without such phenomenon.  
 
This phenomenon was due to bulk copolypeptide precipitation in aqueous 
solution for samples with L segments greater than 28, as described in the text on 
p. 20-21, and shown in Table 2. Once copolypeptide precipitates, its ability to 
contribute to gelation of water via hydrated network formation is diminished. As 
stated in the text, DCHMM stiffness did not decrease as much as DCMMO at higher 
L lengths most likely due to increased solubility of the ionic MM segments vs. the 
non-ionic MO segments. Our data on partially ionic DCHMOK samples (shown in 
Figure 4) support this hypothesis. 
 
Also, in Fig. 3, it is not clear why the authors change to L24? It would be better to 
keep consistency for data comparison.   
 
Samples with shorter L24 segments were used in Figures 3 and 4 since we 
chose these compositions for all subsequent cell and animal studies, and wanted 
to evaluate how these compositions behaved in ionic media, similar to how they 
would be used for biological experiments. The L24 samples were chosen for 
biological studies since their mechanical properties (e.g. stiffness) were similar to 
values we have previously found useful in hydrogels for central nervous system 
applications. This rationale for sample choice was added to the text on p.22 and 
24.  
 
4. In Fig. 5, it is not clear why the cell viability of DCHMM is lower than that 
in DCHMO. Is it because of cytotoxicity or other factors such as mechanical 
property?  
 
The cell viability in presence of DCHMM is lower due to toxicity of the cationic 
hydrophilic segments. This is a well known phenomenon within the literature, and 
we discussed this on page 24, with reference to cationic lysine based hydrogels, 
which are also cytotoxic. The toxicity is not due to mechanical properties, since 
3 
non-ionic DCHMO of near identical composition were found to be significantly less 
cytotoxic.  
 
5. Although the effects of ionic media and amino acid composition have 
been tested in this paper, the mechanism behind did not comprehensively 
discussed, investigated and addressed. The scientific impact of this study is low.  
 
We presented and discussed the effects of amino acid composition on hydrogel 
formation and properties, and quantified these changes using a variety of 
rheology measurements (i.e. Figures 1 and 2). We also presented and discussed 
the effects of different, biologically relevant, ionic media on different hydrogel 
compositions, and quantified the effects of ionic media as a function of ionic 
content in the hydrogels using a variety of rheology measurements (i.e. Figures 3 
and 4). We feel these detailed studies are comprehensive for the purposes of 
evaluating these new hydrogels for biological/biomaterial uses. We also provided 
discussion on interpretations of the results based on observations made in this 
work, as well as previous work by our lab and others on similar materials (p.20-
23).  
 
6. In Fig. 7, only in vitro 2D monolayer cell culture condition is 
demonstrated in this work. However, 3D model should be considered to provide 
more convincible evidence and potential benefits of their Met Based DCH 
hydrogel. Although NSPC has been transplanted into mouse, it is healthy animal 
model but not disease CNS model. No therapeutic potential can be evaluated 
based on this aspect.    
 
The work described in Figure 7 is intended to demonstrate the influence of 
polypeptide hydrophilic chain properties on NSPC differentiation outcomes in a 
serum rich (FBS) environment. The coated substrate assay used here was 
deemed the best way to probe to the cellular interactions with the different 
polypeptide species (the various Met based DCH and gelatin) in this serum 
environment. Specifically, this assay set up removes the effect of any potential 
confounders from other properties of these different polypeptides that are present 
in a 3D culture such as the polypeptide concentration necessary for gelation and 
the porosity of the hydrogel which would both influence the extent of FBS 
perceived by the NSPC, which is fundamental to this assay. Based on this we 
affirm that the assay design was appropriate for the experimental hypothesis 
being tested.  Towards understanding how cell suspension within a 3D hydrogel 
effects cell differentiation we evaluated the effect of NSPC suspension within Met 
based DCH by qPCR (see Supplementary Figure 10 of the original manuscript, 
which is now Supplementary Figure 11 in the updated manuscript) which 
demonstrates that the gene expression of canonical neural stem cell markers for 
the NSPC are unchanged after 6 hours of incubation in DCHMO.  
 
As first proof of principle in vivo experiments we transplanted NSPC loaded in 
DCHMO into healthy, uninjured mouse brains. This is a widely accepted approach 
4 
used throughout the neural stem cell and biomaterial literature to evaluate a new 
neural stem cell line and/or biomaterial in order to assay biomaterial CNS 
compatibility, how grafted cells interact with host neural tissue, and to evaluate 
spontaneous differentiation outcomes of grafted cells in vivo. We affirm that this 
is a necessary and important first step before investigating grafting the NSPC in 
an injury model. We clearly articulate this point in the manuscript and we also 
specify in the discussion section our intent in future work to use these cells in 
CNS injury models.   
 
7. In the Abstract line 46, the authors mention that DCH can assemble into 
hydrogels and display self-healing behavior. However, the self-healing property 
did not reveal in the result data.    
 
Self-healing properties of DCHMO and DCHMM were described and quantified in 
Figure 1D and Figure 2D, respectively, as well as on p.21 in the text. Also, we 
have explicitly added “self-healed to recover elastic properties” for the section on 
DCHMO, while “self-healing” was already included in the section for DCHMM. 
 
8. From the "Guides to Authors", all manuscripts are to be supplied with an 
abstract of about 100-200 words in length. Obviously, the abstract of this paper 
manuscript is 255 words, more than 200 words; thus, should be shortened.    
 
We appreciate the reviewer’s thoroughness in evaluating the length of our 
abstract. We have made efforts to shorten it and have updated it within the 
manuscript.  The abstract is now 200 words.   
 
9. The Introduction is lengthy and can also be shortened to be more neatly 
and precisely.    
 
We have shortened the introduction without distorting the important background 
information presented and have updated it within the manuscript.   
 
10. The number of References is 78. The number of self-citation papers are 
also very high. I strongly suggest the authors to prevent over-citation of their own 
paper works.     
 
We have reduced the number of self-citations by 9 and now have an overall total 
of 68 citations.  
 
11. Too many abbreviations used in this manuscript (viz., K180L20, DCHK , 
rac-EP2, DCHEO, DCHMM , DCHMO , DCHMOK , DCH27 , MR, MO, MA170Ln, 
(MOA)170Ln ,  (MOxKy)170L23, (MMA)170Ln , Mm, MAm, MOAm, etc) making 
it extremely difficult for the readers to correctly understand and grasp the 
important points and idea of this paper work. This may distract the major focus of 
this study and make readers feel very confused in the jungle.  
 
5 
Our manuscript describes the development of new copolypeptide hydrogel 
precursors (based on methionine), the subsequent modification of these 
precursors to generate samples with different functionality, and the formulation of 
these copolypeptides into hydrogels. To concisely and adequately describe this 
large set of molecules and materials, we have developed a systematic method of 
nomenclature that is unambiguous and is used universally across nearly all of 
our publications on copolypeptides. Many of the abbreviations used here refer to 
abbreviations used in prior manuscripts (e.g. rac-EP2, K180L20, DCH, MO, MM, 
etc.), and changing them here would lead to inconsistency and confusion. We 
have defined all abbreviations in the text where they first appear, which is usually 
considered adequate. 
 
 
Reviewer #5:  
The manuscript describes systematic development of new hydrogels diblock 
copolypeptide hydrogels, which are improvement over previous work of the 
authors aiming for cytocompatible materials stimulating central nervous system 
regeneration. Overall, the manuscript is well written and contains novel work. It is 
based on thorough and systematic evaluation of physical properties through a 
range of materials, however the final in vivo work concluding the manuscript is 
missing important controls making it less attractive to biomaterials audience.   
 
Authors state that the cells were subcultured over several passages. Please 
provide information about the passage number of NSPC used for the 
experiments.  
 
NSPC stocks that had undergone 15-24 passages (5-8 weeks of neural 
expansion) were used for experimental studies.  We performed qPCR on 
samples derived from NSPC across this passage range and confirmed no 
change in gene expression of canonical neural stem cell markers. This 
information has been included in the methods section of manuscript.   
 
Page 28 lane 34 - authors say that the in vivo viability of the engrafted cells is 
excellent. Survival is impossible to determine in vivo. Fraction of the injected cells 
survived, but overall viability can't be claimed as "excellent". The in vivo 
experiment would benefit from showing a control where mice were injected with 
hydrogel only to show the hydrogel specific host tissue reaction to the material, 
as well as cell injection alone, without the hydrogel. Without these two controls 
the experiment is very descriptive and does not allow for full evaluation of the 
hydrogel effects. Moreover, since the work aims on development of improved 
materials, the state-of-the-art material should be used to as a another control to 
determine if the changes to material chemistry resulted in the intended 
improvement in vivo. I strongly suggest to authors to repeat in vivo experiments 
with appropriate set of controls, which will allow to determine and quantify the 
outcomes of hydrogel/NSPC implantation.  
 
6 
The sentence identified by the reviewer on Page 28 lane 34 in the original 
manuscript does not refer to the viability of the grafted NSPC as suggested by 
the reviewer but rather states that the viability of the host tissue (neuronal and 
astroglial cells) in proximity to the graft is good. We have edited the language 
used in this sentence to avoid any confusion on this point. It should be noted that 
we do not make any claims about the extent of viability of the grafted cells in the 
manuscript other than the fact that cells did survive in sufficient numbers to easily 
evaluate their cellular identity and their interaction with host tissue. 
 
The in vivo work included in this manuscript is a first proof of principle evaluation 
of how grafted cells interact with host neural tissue, and an evaluation of 
spontaneous differentiation outcomes of grafted cells in vivo using this new 
biomaterial/NSPC line combination.  
 
We thank the reviewer for suggesting the inclusion of a control where mice were 
injected with hydrogel only to show the hydrogel specific host tissue reaction to 
the material. To address this we have included a new supplementary panel (now 
Supplementary Figure 10 in the newly updated manuscript) that compares the 
foreign body response of DCHMO alone with a saline control in uninjured mouse 
brain at 1 week. DCHMO alone caused minimal host CNS tissue disruption. 
Specifically, the proximal neuronal survival as well as the extent and magnitude 
of the reactive astroglial response for the DCHMO was comparable to that of the 
saline injection.  
 
Regarding the suggestion for a comparison with cells grafted with or without 
hydrogel, or comparison with other hydrogel formulations, we consider that 
performing a detailed study of this kind is far beyond the scope of this current 
manuscript which focuses on the development and characterization of this new 
material and NSPC line. A study of this kind requires detailed and rigorous 
evaluations, and we will conduct such evaluations and comparisons as a 
requisite demonstration for our next manuscript. Meanwhile, we attest that the 
work described here shows that we have an improved biomaterial in a number of 
ways. Specifically, the new DCH formulations allow for improved ease of 
synthesis, allow for improved functionalization and demonstrate more versatile 
physiochemical properties than other predecessor materials. These 
advantageous attributes of the new hydrogel are key points made within this 
manuscript.   
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Abstract: 
Injectable hydrogels with tunable physiochemical and biological properties are potential 
tools for improving neural stem/progenitor cell (NSPC) transplantation to treat central 
nervous system (CNS) injury and disease. Here, we developed injectable diblock 
copolypeptide hydrogels (DCH) for NSPC transplantation that contain hydrophilic 
segments of modified L-methionine (Met). Multiple Met-based DCH were fabricated by 
post-polymerization modification of Met to various functional derivatives, and 
incorporation of different amino acid comonomers into hydrophilic segments. Met-based 
DCH assembled into self-healing hydrogels with concentration and composition 
dependent mechanical properties. Mechanical properties of non-ionic Met-sulfoxide 
formulations (DCHMO) were stable across diverse aqueous media while cationic 
formulations showed salt ion dependent stiffness reduction. Murine NSPC survival in 
DCHMO was equivalent to that of standard culture conditions, and sulfoxide functionality 
imparted cell non-fouling character. Within serum rich environments in vitro, DCHMO was 
superior at preserving NSPC stemness and multipotency compared to cell adhesive 
materials. NSPC in DCHMO injected into uninjured forebrain remained local and, after 4 
weeks, exhibited an immature astroglial phenotype that integrated with host neural 
Manuscript with revisions
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tissue and acted as cellular substrates that supported growth of host-derived axons. 
These findings demonstrate that Met-based DCH are suitable vehicles for further study 
of NSPC transplantation in CNS injury and disease models.  
 
Keywords: biomaterials; polypeptides; hydrogels; neural stem cells; brain; cell 
transplantation.  
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1. Introduction 
 
Transplantation of neural stem/progenitor cells (NSPC) has emerged as a potential 
therapy for treatment of central nervous system (CNS) diseases and injuries including 
Parkinson’s, spinal cord injury, and stroke1. NSPC can be readily derived from 
embryonic2,3, adult4-6, and induced pluripotent stem (iPS) sources7 and upon 
transplantation in vivo show a capacity to differentiate into glial and neuronal 
phenotypes that can integrate into host circuitry8,9. In the context of injury or disease, 
NSPC grafting has aided host neuronal survival, axon regeneration, remyelination and 
traumatic lesion re-vascularization10. However, despite their promise, NSPC therapies 
face considerable challenges including: (i) widespread cell graft necrosis and 
apoptosis11,12, (ii) inappropriate differentiation and cell fate decision making, (iii) cellular 
migration away from lesioned/diseased neural tissue resulting in ectopic colonies along 
the brain and spinal cord neuroaxis, and (iv) isolation of cell grafts away from adjacent 
viable neural tissue by graft induced inflammation and fibrosis6,13,14. Inability to address 
these challenges limits the functional potential of NSPC transplantation and hampers 
clinical translation. NSPC transplantation would benefit from innovative bioengineering 
strategies that: (1) enhance survival of injected cells; (2) direct progenitor differentiation 
in vivo; and (3) optimize graft-host interactions. Injectable hydrogel carriers have 
emerged as potential tools to aid NSPC transplantation. To date, fibrin gels have been 
the predominant material of choice in NSPC grafting studies due to their commercial 
availability and straight forward formulation15-17. However, the limited control over 
physical, chemical and mechanical properties of fibrin gels and their inherent and 
uncontrollable bioactivity has prompted efforts to develop alternative synthetic hydrogels 
for NSPC transplantation18,19. 
 
To identify hydrogel properties that influence NSPC transplantation outcomes we and 
others have been focused on engineering injectable synthetic hydrogels with robust 
tunability of physiochemical and biological properties. For example, blends of 
hyaluronan and methylcellulose have demonstrated utility in enhancing the survival of 
grafted NSPCs in models of spinal cord injury20, retinal disease and stroke21. In these 
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studies, a rigorous mechanistic investigation uncovered a pro-survival effect of the 
inclusion of bioactive hyaluronan, which was attributed to its high affinity for CD44 
receptors  on progenitor cells21. Variations in methylcellulose concentration also allowed 
for manipulation of hydrogel mechanical properties, which influenced the injectability 
and overall survival of transplanted NSPC using this system. Other studies using an 
elastin-like protein based hydrogel established that the progenitor state of NSPC is 
modulated by the stiffness and degradability of the suspending matrix 22. 
 
We have developed biomimetic hydrogels for drug delivery and cell transplantation 
using synthetic polypeptides. Polypeptide hydrogels are versatile materials that can: (i) 
be enzymatically degraded, (ii) include a wide range of chemical functionality, (iii) adopt 
ordered conformations that can drive structural and mechanical properties, and (iv) 
respond to biological stimuli1,23. Our synthetic materials are based on amphiphilic 
diblock copolypeptide hydrogels (DCH) that in their first iteration were composed of 
discrete hydrophobic and ionic hydrophilic segments (e.g. poly(L-lysine·HCl)180-block-
poly(L-leucine)20, K180L20 or DCHK)
24,25, and possessed many features attractive for 
CNS applications26,27. DCH are physically associated gels composed of branched and 
tangled nanoscale tape-like assemblies that can be deformed by applied stress and 
injected through narrow diameter cannulae, after which they rapidly re-assemble into 
elastic gel networks24,25. When injected into mouse CNS tissues, ionic DCH self-
assemble into discrete, well-formed deposits of rigid gel networks in vivo that integrate 
well with host CNS tissue, causing no detectable toxicity, and are fully degraded  in 
vivo27. We also reported both in vitro and in vivo evidence that ionic DCH can serve as 
depots for sustained local release of both hydrophilic and hydrophobic effector 
molecules for investigative and potential therapeutic applications in the CNS26. 
 
Although they have many advantageous properties as hydrogels in vivo, one limitation 
of ionic DCH is their cytotoxicity towards cells encapsulated completely within the 
material matrix28, which precludes their use in cell grafting applications. To obtain cell-
compatible hydrogels, we focused on creating non-ionic DCH, since non-ionic polymers 
and hydrogels are well known to be less toxic to cells in vitro29. In an initial proof of 
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concept study, we developed DCH containing non-ionic poly(-[2-(2-
methoxyethoxy)ethyl]-rac-glutamate), rac-EP2, hydrophilic segments instead of charged 
polypeptide segments, and found the resulting hydrogels, termed DCHEO, retained the 
advantageous physical properties of ionic DCH, as well as displayed no significant 
cytotoxicity to either mesenchymal stem cells or NSPC for periods up to 7 days in vitro. 
Furthermore, DCHEO demonstrated improved cell viability, localization and host 
integration of NSPC grafted into crush spinal cord injury lesions compared to that 
afforded by culture media alone28. The enhanced performance was attributed to 
superior suspension of the NSPCs and a more even distribution of grafted cells within 
the SCI lesion afforded by DCHEO. While DCHEO are promising as cell carriers, the 
chemistry of the rac-EP2 component limits the further development and utility of these 
hydrogels. In addition to being composed of unnatural amino acids that require 
additional synthesis steps and purification, hydrolysis of side-chain linkages may lead to 
premature degradation of the DCHEO in aqueous media. The reactivity of side-chain 
ester linkages also prohibits the incorporation of other protected functional monomers 
into DCHEO, since most deprotection conditions will also cleave off the diethylene glycol 
chains from the glutamate residues. 
 
In the study presented here, we sought to overcome the synthesis and functionality 
limitations associated with DCHEO by utilizing new methods for post-polymerization 
modification of L-methionine (Met) residues in copolypeptides30 to enable scalable 
synthesis and add new capabilities beyond those in DCHEO. Met is an essential amino 
acid in living systems with rich biochemistry. For example, Met residues can be 
selectively alkylated to give sulfonium salt derivatives that allow for the introduction of 
ionic groups in polypeptides31,32. This chemistry has been used to convert hydrophobic, 
-helical poly(L-methionine), M, into a wide variety of water soluble, ionic poly(S-alkyl-L-
methionine sulfonium)s, MR, containing diverse functionality33. Alternatively, Met 
residues can also be readily and selectively oxidized to give highly polar, non-ionic L-
methionine sulfoxide, MetO, residues34-36. Polymers containing MetO residues have 
shown interesting physiochemical and biological properties that may be advantageous 
for their use in hydrogels for NSPC transplantation 37-41. For example, membranes of 
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poly(L-methionine sulfoxide), MO, demonstrated enhanced water permeability compared 
to parent, non-oxidized, M polymers37,38, as well as improved solubility and transport of 
hydrophilic polypeptide drugs and hydrophobic small molecules39. Furthermore, MO 
chains have been found to exhibit negligible diffusion across cell membranes, and 
sulfoxide groups in polymers and on surfaces have been found to impart inherent 
resistance against protein adsorption. The mechanism of this exceptional protein and 
cell non-fouling character has been attributed to the capacity of sulfoxide groups to act 
as hydrogen bond acceptors but not donors, analogous to how ethylene oxide groups 
contribute to protein adsorption resistance in polyethylene glycol based materials 42-44. 
These characteristics suggest that MO may be an excellent component for biomaterial 
formulations with negligible in vitro or in vivo cytoxicity41,45-47. Additionally, since 
biological systems contain catabolic enzymatic mechanisms to readily reduce MetO 
residues in proteins back to Met, and we have shown MO polymer can be readily 
degraded by proteolytic enzymes in vitro40, MO based biomaterials should be readily 
and safely resorbed in vivo48. 
 
Given the numerous advantages described above, both alkylated and oxidized M chains 
represent potentially attractive candidates as hydrophilic segments in DCH intended for 
use in NSPC grafting applications. The abundance and low cost of the precursor Met 
amino acid, the ease of synthesis and purification of Met NCA monomer, and high yield 
polymerization and post-polymerization modification reactions49 allow the modified Met-
based DCH platform to be readily scalable and amenable to being manufactured in 
compliance with GMP standards that would be required for human use. Here, we outline 
the design and synthesis of modified Met-based DCH materials, demonstrate the 
tunable physiochemical and biological properties achieved through post-polymerization 
modifications of the Met residues, and establish the utility of specific formulations of 
Met-sulfoxide based DCHMO for NSPC transplantation applications.  
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2. Materials and Methods 
 
2.1. Synthesis and characterization of copolypeptides 
2.1.1. Materials and Instrumentation 
Tetrahydrofuran (THF), hexanes, and methylene chloride were dried by purging with 
nitrogen and passage through activated alumina columns prior to use. Triethylamine 
(TEA) and trimethylsilyl chloride (TMSCl) were purified by distillation and stored over 3 
Å molecular sieves. Co(PMe3)4, L-methionine, L-leucine, and L-alanine amino acid N-
carboxyanhydride (NCA) monomers were prepared according to literature procedures 
27,49,50. All other chemicals were purchased from commercial suppliers and used without 
further purification unless otherwise noted. Selecto silica gel 60 (particle size 0.032– 
0.063 mm) was used for flash column chromatography. Fourier Transform Infrared 
(FTIR) measurements were taken on a Perkin Elmer RX1 FTIR spectrophotometer 
calibrated using polystyrene film, and attenuated total reflectance infrared (ATR-IR) data 
were collected using a PerkinElmer Spectrum 100 FTIR spectrometer equipped with a 
universal ATR sample accessory. 1H NMR spectra were acquired on a Bruker ARX 400 
spectrometer. Tandem gel permeation chromatography/light scattering (GPC/LS) was 
performed at 25 oC using an SSI Accuflow Series III pump equipped with Wyatt DAWN 
EOS light scattering and Optilab REX refractive index detectors. Separations were 
achieved using 100 Å and 1000 Å PSS-PFG 7 m columns at 30 ºC with 0.5% (w/w) 
KTFA in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) as eluent and sample concentrations 
of 10 mg/ml. Pyrogen free deionized water (DI) was obtained from a Millipore Milli-Q 
Biocel A10 purification unit. Dialysis was conducted using regenerated cellulose dialysis 
tubing (Spectrum Labs). 
 
2.1.2. Preparation of N-Boc-L-lysine NCA 
The preparation of N-Boc-L-lysine NCA was modified from a procedure in literature51.  
To a solution of N-Boc-L-lysine amino acid (1 equiv) in dry THF (0.15 M) in a Schlenk 
flask was added TEA (2 equiv) and TMSCl (2 equiv) via syringe. The reaction was 
stirred under N2 at 20 ºC for 1 hour. Upon addition of TEA and TMSCl, precipitation of 
TEA·HCl was observed. Phosgene solution in toluene (15% (w/v), 2 equiv) was then 
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added via syringe and the reaction was stirred under N2 at 50 ºC for 2 hours. Caution! 
Phosgene is extremely hazardous and all manipulations must be performed in a well-
ventilated chemical fume hood with proper personal protection and necessary 
precautions taken to avoid exposure.  After 2 hours, the reaction was evaporated to 
dryness and transferred into a N2 filled glovebox. In the fume hood, the condensate in 
the Schlenk line vacuum traps was treated with 50 mL of concentrated aqueous NH4OH 
to neutralize residual phosgene.  In the glove box, the insoluble TEA·HCl was removed 
by dissolving the product in 30% THF in hexanes and passing through a plug of vacuum 
dried silica49. The combined NCA containing fractions were dried under reduced 
pressure and the product was dissolved in a minimal amount of THF and crystallized by 
addition of hexanes (1:3 THF:hexanes).  Multiple crystallizations (5x) were required for 
adequate NCA purification (overall yield = 52%). 1H NMR and FTIR spectral data were 
consistent with previously reported values from literature52. 
 
2.1.3. General Copolypeptide Synthetic Procedure 
All polymerization reactions were performed in a N2 filled glove box using anhydrous 
solvents. To prepare copolypeptide at ca. 100 mg scale, a solution of Co(PMe3)4 (4.5 
mg, 0.012 mmol) in THF (20 mg/mL) was quickly added to a solution of L-methionine 
NCA (Met NCA; 100 mg, 0.57 mmol) and L-alanine NCA (Ala NCA; 7.3 mg, 0.063 
mmol) in THF (50 mg/mL). To synthesize lysine containing copolypeptides, Ala NCA in 
the above procedure was replaced with N-Boc-L-lysine NCA (Boc-Lys NCA) at the 
desired molar ratio. After ca. 60 min., complete consumption of NCA was confirmed by 
FTIR spectroscopy.  In order to determine the lengths of poly(L-methionine-stat-L-
alanine), MA, or poly(L-methionine-stat-Boc-L-lysine), MKBoc, segments, a small aliquot 
(200 µl) of each polymerization mixture was removed for end-group analysis (vide infra). 
To each remaining copolymerization mixture was then added L-leucine NCA (Leu NCA; 
5.9 to 20 mg, 0.038 to 0.13 mmol) in THF (50 mg/mL). The Leu NCA monomers were 
found to be completely consumed within ca. 60 min., and the reaction mixtures were 
subsequently removed from the glove box. The block copolypeptide solutions were then 
precipitated by addition to a 0.1 M aqueous HCl solution (75 mL), filtered, washed with 
DI water, and dried under reduced pressure to yield white fluffy solids with yields 
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ranging from 90 to 95%. Detailed compositional and characterization data for all 
samples are provided in the Supplementary Information. 
 
2.1.4. Sample procedure for MAm chain length determination using end-group 
analysis 
In the glove box, α-methoxy-ω-isocyanoethyl-poly(ethylene glycol)23 (mPEG23-NCO)
53 
(20 mg) was dissolved in THF (1 ml) in a 20 ml scintillation vial. An aliquot (200 µl) of 
copolymerization solution containing active chain ends (from 2.1.3 above) was removed 
and added to the solution of mPEG23-NCO. The PEG end-capped sample (e.g. MAm-
mPEG23) was sealed, allowed to stir for 24 h, and then used for chain length 
determination. Outside of the glove box, the PEG end-capped sample was washed with 
10 mM aqueous HCl (2x). After stirring for 1 h, MAm-mPEG23 was collected by 
centrifugation and washed with DI water (3 x 20 ml) to remove all non-conjugated 
mPEG23-NCO. The remaining MAm-mPEG23 was then freeze-dried to remove residual 
H2O. To determine MAm molecular weights (Mn), 
1H NMR spectra were obtained. Since 
it has been shown that end-capping is quantitative for (PMe3)4Co initiated NCA 
polymerizations when excess isocyanate is used53, integrations of methionine (δ 2.70) 
and alanine (δ 1.52) resonances versus the polyethylene glycol resonance at δ 3.92 
could be used to obtain both the ratios of M to A and MAm lengths. 
 
2.1.5. Procedure for Oxidation of Met Residues in Copolypeptides 
For Boc-Lys containing copolypeptides, deprotection was performed before oxidation of 
Met residues (see 2.1.7). To convert Met residues in copolypeptides to Met sulfoxide 
residues, a volume of 70 wt. % tert-butyl hydroperoxide (TBHP) (16 molar equivalents 
per Met residue) was added to a sample of solid copolypeptide (ca. 80 mg). The 
reaction mixture was then diluted with DI water to yield an overall polypeptide 
concentration of ca. 20 mg/mL. To aid oxidation, a catalytic amount of camphorsulfonic 
acid (CSA) (0.2 molar equivalents per Met residue) solution in DI water (20 mg/ml) was 
subsequently added. The reaction mixture was stirred vigorously for 24 hours at 
ambient temperature, whereupon complete dissolution of copolypeptide samples was 
observed. Reaction mixtures were transferred to 2000 MWCO dialysis bags and 
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dialyzed against: (i) pyrogen free deionized milli-Q water (3.5L) containing sodium 
thiosulfate (1.2 g, 2.16 mM) for 2 days to neutralize residual peroxide, (ii) milli-Q water 
(3.5L) acidified to pH 4 with HCl for 2 days to aid cobalt ion removal, and (iii) milli-Q 
water (3.5L) for 2 days to remove residual HCl.  For each step dialysate was changed 
every 12 hours.  Copolypeptide solutions were then freeze dried to yield white fluffy 
solids with average yields of 90 to 95%, and 100% conversion of Met residues to Met 
sulfoxide groups. 
 
2.1.6. Procedure for Methylation of Met Residues in Copolypeptides 
To convert Met residues in copolypeptides to S-methyl-Met sulfonium residues, 
iodomethane (3 equivalents per Met residue) was added to suspensions of 
copolypeptides (ca. 80 mg) in DI water (ca. 20 mg/ml). Reaction mixtures were covered 
with aluminum foil to protect iodomethane from light, and then stirred vigorously for 5 
days at ambient temperature.  After 5 days, reaction mixtures were found to be 
suspensions of particulates. The copolypeptides were subsequently transferred to 2000 
MWCO dialysis bags and dialyzed against: (i) pyrogen free deionized milli-Q water 
(3.5L) containing sodium metabisulfite (0.50 g, 0.75 mM) for 1 day to remove iodine 
based impurities, (ii) milli-Q water (3.5L) acidified to pH 4 for 2 days to aid cobalt ion 
removal, (iii) milli-Q water containing NaCl (7.0 g, 35 mM) for 2 days to facilitate iodide 
to chloride counterion exchange, and (iv) milli-Q water (3.5L) for 2 days to remove 
residual NaCl.  For each step dialysate was changed every 12 hours.  After dialysis all 
copolypeptides were completely soluble in DI water. Copolypeptide solutions were then 
freeze dried to yield white fluffy solids with average yields of 95 to 99%, and 99% 
conversion of Met residues to S-methyl-Met sulfonium groups. 
 
2.1.7. Deprotection of Boc-Lys containing copolypeptides 
Deprotection of Boc-Lys was performed before oxidation of Met residues. To facilitate 
deprotection, Boc-Lys containing copolypeptides (ca. 80 mg) were fully dissolved in 
trifluoroacetic acid (ca. 25 mg/mL) and stirred at ambient temperature for 2 hours. 
Copolypeptide samples were then precipitated into diethyl ether (75 mL). The diethyl 
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ether was decanted away and the copolypeptides were dried under reduced pressure 
overnight to yield white solids (ca. 99% yield, 100% deprotection efficiency). 
 
2.1.8. Preparation of DCH Formulations 
DCH were prepared by solubilizing lyophilized copolypeptide in either DI water, 
phosphate buffered saline (PBS), or cell culture media and allowing to assemble for 24 
hours, without stirring, before use. 
 
2.1.9. Circular Dichroism 
All circular dichroism spectra were collected using an OLIS RSM CD spectrophotometer 
(OLIS, USA) using conventional scanning mode. Poly(L-methionine sulfoxide), MO, and 
poly(L-methionine sulfoxide-stat-L-alanine), MOA, samples were characterized by 
recording spectra (185-260 nm) within a quartz cuvette of 0.1 cm path length.  Samples 
were prepared at concentrations of 0.10 to 0.17 mg/mL in Milli-Q water.  The spectra 
are reported in units of molar ellipticity [θ] (deg∙cm2∙dmol-1), which was calculated using 
[θ] = (θ x 100 x MW)/(c x l) where θ is the measured ellipticity (millidegrees), MW is the 
average residue molecular mass (g/mol), c is the polypeptide concentration (mg/mL), 
and l is the cuvette path length (cm). 
 
2.2. DCH Characterization 
2.2.1. Dynamic Mechanical Rheology 
Dynamic rheological measurements were performed at constant set temperature of 25 
°C using a Physica MCR 301 (Anton Paar, Sweden) equipped with a 25 mm 1° cone 
and plate geometry.  To determine the linear viscoelastic testing region for each DCH 
sample a frequency sweep from 0.1 to 100 rad s-1 at a fixed strain of 0.5% was applied 
followed by a strain sweep from 0.1 to 100% strain at a fixed frequency of 10 rad s-1. 
DCH samples were allowed to recover for a period of 2 minutes between individual 
rheological experiments.  To compare mechanical properties across various DCH 
samples a time sweep under fixed strain and frequency conditions (0.5% strain and 10 
rad s-1) was applied for one minute. To evaluate shear thinning and recovery behavior 
of DCH the strain amplitude parameters were stepped from 0.5% to 1000%, maintained 
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at 1000% for 2 minutes and then returned to 0.5% to evaluate the recovery of the 
mechanical properties at a fixed frequency of 10 rad s-1. 
 
2.3. In vitro cell culture 
2.3.1. Neural stem/progenitor cell (NSPC) derivation and culture 
Neural stem/progenitor cells (NSPC) used in this study were derived from mouse 
embryonic stem cells (mESC). The mESC lines used in this study contain a Ribotag (a 
modified ribosomal protein L22 (Rpl22) with hemagglutinin epitope tag)54 allele. The 
mESC lines were derived from the inner cell mass of E3.5 blastocyst stage embryos 
generated from crosses of male homozygous B6N.129-Rpl22tm1.1Psam/J(StockNo: 
011029) “Ribotag” mice to females hemizygous for a dominant, maternal effect cre 
allele, B6.Cg-Tg(SOX2-cre)1Amc/J (StockNo: 008454) and heterozygous for the 
“Ribotag” allele. Multiple male and female mESC lines were derived, and each was 
karyotyped and genotyped to confirm sex and homozygosity for the cre-exised, Ribotag 
allele. For generation of NSPC an induction and expansion method reported widely 
within the literature was used55-57. Briefly, mESC were maintained and expanded on 
gelatin-coated plates in DMEM media containing a cocktail of supporting growth factors 
including Leukemia inhibitory factor (LIF) (EMD Millipore, Burlington, MA), ES grade 
Fetal Bovine Serum (FBS), nucleosides, non-essential amino acids and β-
mercaptoethanol (Thermofisher Scientific). The neural induction of mESC was 
performed using a 2-/4+ protocol described in detail previously55. Specifically, 2X106 
mESC were cultured for two days in LIF free differentiation media (Advanced 
DMEM/F12 media supplemented with knockout serum (Thermofisher Scientific), 
glutamine, nucleosides, non-essential amino acids and -mercaptoethanol) under non-
adherent suspension conditions to promote the formation of embryoid bodies (EB). After 
two days the EBs were transferred to gelatin coated flasks and cultured for four days in 
differentiation media supplemented with 50 nM retinoic acid (RA) and 500nM 
purmorphamine (PUR)(sonic hedgehog (SHH) agonist) to caudalize and neurally induce 
(NI) the cells55. Differentiation media with the RA/PUR morphogens was replaced after 
two days. Following neural induction the cells were subsequently expanded for several 
passages in neural progenitor cell media (Advanced DMEM/F12 supplemented with 
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B27 (Thermofisher Scientific), nucleosides, non-essential amino acids, heparin and 
FGF/EGF (Peprotech) both at 100 ng/ml) to generate a population of definitive NSPC 
for in vitro studies.  NSPC stocks that had undergone 15-24 passages (5-8 weeks of 
neural expansion) were used for experimental studies.   
 
2.3.2. In vitro DCH NSPC viability evaluation 
To evaluate hydrogel cytotoxicity, NSPC were suspended within DCH formulations and 
placed on top of 1% agarose molds containing unsupplemented Advanced DMEM/F12 
media to ensure maintenance of hydrogel hydration. For each formulation 5000 cells/µL 
of hydrogel were suspended within the material and 30 µL of hydrogel/cell solution was 
added on top of the agarose molds. Each hydrogel sample was studied in triplicate. 
After 24 hours of incubation, hydrogels were thinned into liquids by dilution into 100 µL 
of 1X PBS containing 2 μM Calcein AM to identify viable cells and 4 μM EthD-1 to 
identify dead cells and allowed to incubate at room temperature for 30 minutes. Cell 
solutions were then transferred to glass slides, coverslipped and imaged using the FITC 
and Rhodamine filters on an epi-fluorescent microscope (Zeiss). At least five images 
per slide were collected resulting in a total of 15 images per hydrogel sample. Cell 
viability was normalized to the viability of cells incubated in media alone. 
 
2.3.3. NSPC adhesion to DCH coated substrates 
Hydrophobic, siliconized circular glass coverslips (12mm) (Hampton Research, Aliso 
Viejo, CA) or black 96 well untreated polystyrene plates (Brand, Germany) were coated 
with an appropriate volume of 0.1 wt% copolypeptide solubilized in 70% ethanol. After 
being allowed to adsorb for 1 hour, copolypeptide solutions were aspirated and the 
coated surfaces allowed to dry for 1 hour under ambient conditions. Before plating the 
cells, coated surfaces were washed once with water to remove any non-adsorbed 
copolypeptide. Cells were seeded at 200,000 and 100,000 cells for the coverslips and 
wells respectively and incubated on coated surfaces for 24 hours before analysis. For 
the coated coverslips, the cells were imaged under brightfield conditions using an EVOS 
XL cell imaging system (Thermofisher Scientific). After the 24 hour incubation period the 
96 well plate was washed once with 1x PBS to remove non-adhered cells and the plate 
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was then treated with 1x PBS containing 2 μM Calcein AM and 4 μM EthD-1 for 30 
minutes to identify viable cells that remained adhered to the plate. The 96 well plate was 
read on a VICTOR 2V Multilabel fluorescent plate reader (Perkin Elmer). Quantification 
of cell attachment was normalized to a gelatin coated substrate which demonstrated the 
highest extent of cell adhesion. 
 
2.3.4. NSPC differentiation on DCH substrates 
To study the influence of cellular substrate interactions on NSPC differentiation 
outcomes, 100 mm non-treated polystyrene petri dishes were coated separately with 
DCHMO, DCHMM or gelatin. As in the adhesion experiments above, a 0.1 wt% 
copolypeptide solubilized in 70% ethanol was applied to each petri dish, allowed to 
incubate and dry for 1 hour and then washed once with water to remove non-adsorbed 
material. NSPC were seeded at a 2X106 cells/plate and cultured for 48 hours in media 
containing 10% FBS.  After 48 hours cells were trypsinized and re-seeded on gelatin 
coated coverslips and cultured for an additional 72 hours in supplement free media to 
promote spontaneous differentiation. 
 
2.3.5. Immunocytochemistry 
Cell seeded coverslips were washed with 1x PBS and fixed for 30 minutes with 4% 
paraformaldehyde. Coverslips were then washed with TBS buffer, blocked and 
permeabilized with donkey serum and Triton X-100 in TBS buffer before being stained 
overnight with primary antibodies. Primary antibodies used within the in vitro 
experiments included: (i) rat anti mouse-GFAP (Thermofisher, #13-0300, 1:1000 
dilution) (ii) rabbit anti mouse-TUJ-1 (Sigma, #T2200, 1:1000 dilution), (iii) goat anti-
mouse-HA (Novus, NB600-362, 1:1000 dilution), (iv) rabbit anti-mouse HA (Sigma, 
H6908, 1:1000 dilution), (v) goat anti-mouse SOX2 (R&D Systems, AF2018, 1:300 
dilution), (vi) goat anti-mouse SOX9 (Novus, H00006662-M02,1:200 dilution) (vii) 
chicken anti-mouse NESTIN (Novus, NB100-1604, 1:500 dilution). Fluorophore-
conjugated secondary donkey antibodies (Jackson ImmunoResearch) raised against 
the various primary antibody species were applied for 2 hours. Coverslips were 
subsequently stained for DAPI and mounted on glass slides. 
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2.3.6. PCR 
NSPCs were seeded on DCHMO, DCHMM or gelatin coated 100 mm non-treated 
polystyrene petri dishes at 6x106 cells per plate and cultured in NSPC media containing 
10% FBS. At 48 hours cells were lysed and mRNA isolated using the RNEasy® Plus 
Mini RNA purification kit (Qiagen) following the manufacturer’s instructions. Isolated 
mRNA was quantified by UV/VIS and 500ng of mRNA was used to synthesize cDNA 
using the iScriptTM Reverse Transcription Supermix reagent (Biorad). qPCR was 
performed as a 10 µL reaction volume in a 96 well PCR plate on a Lightcycler 96 
instrument (Roche) and incorporating SsoAdvanced™ Universal SYBR® Green 
Supermix (Biorad) and various primers (Supplementary Table 1). Relative gene 
expression was determined by comparing ∆ct values for each experimental condition 
that were normalized to the Ribotag (HA) gene expression. 
 
2.4. In vivo DCH injections 
2.4.1. Surgery 
All surgical procedures used adhere to a protocol approved by the UCLA animal 
research committee. Wildtype C57BL/6 mice (8-12 weeks) were used for all 
experiments. For DCH injections, mice were anesthetized using isoflurane and a 
craniotomy performed using a high speed surgical drill.  A volume of 1 μL of DCH was 
injected into the caudate putamen nucleus at 0.15 μL/min using target coordinates 
relative to Bregma: +0.5 mm A/P, +2.5mm L/M and -3.0 mm D/V. DCH injections were 
made using pulled glass micropipettes ground to a beveled tip with 150–250 μm inner 
diameter attached via specialized connectors and high-pressure tubing to a 10 μL 
syringe that was mounted to a stereotaxic frame and controlled by an automated 
microdrive pump. 
 
2.4.2. Immunohistochemistry 
At 4 weeks after hydrogel injection mice underwent transcardial perfusion with 
heparinized saline and 4% paraformaldehyde (PFA), and the brain was excised for 
histological analysis. Following an 8 hour post fixation in 4% PFA and a 72hr incubation 
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in 30% sucrose, 40 µm coronal sections of brain were prepared using a cryostat. Tissue 
sections were stained as free floating sections using standardized 
immunohistochemistry techniques described by us elsewhere26. Specific antibodies 
used to stain brain tissue sections included: (i) rat anti mouse-GFAP (Thermofisher, 
#13-0300, 1:1000 dilution) (ii) rabbit anti mouse-TUJ-1 (Sigma, #T2200, 1:1000 
dilution), (iii) goat anti-mouse-HA (Novus, NB600-362, 1:1000 dilution), (iv) rabbit anti-
mouse HA (Sigma, H6908, 1:1000 dilution), (v) goat anti-mouse SOX2 (R&D Systems, 
AF2018, 1:300 dilution), (vi) goat anti-mouse SOX9 (Novus, H00006662-M02,1:200 
dilution), (vii) goat anti-mouse NESTIN (R&D Systems, AF2736, 1:800 dilution), (viii) 
rabbit anti-mouse ALDH1L1 (Abcam, ab87117, 1:500), (ix) rabbit anti-mouse S100β 
(Abcam, Ab41548, 1:1000), (x) rabbit anti-mouse NEUN (Abcam, AB177487, 1:800); 
(xi) rabbit Neurofilament M (NFM) (EMD Millipore, AB1987, 1:1000). Fluorophore 
conjugated secondary donkey antibodies (Jackson Immuno-Research) raised against 
the various primary antibody species were applied for 2 hours. Tissue sections were 
stained for DAPI before being mounted on glass slides and coverslipped with ProlongTM 
Gold antifade mounting medium (Invitrogen). 
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3. Results 
3.1. Synthesis of non-ionic and cationic Met-based DCH 
 
3.1.1. Design and synthesis of Met-based DCH precursors 
Using previous DCH as models, new copolypeptides were designed as amphiphilic 
diblock copolymers with conformationally disordered, hydrophilic modified poly(L-
methionine), M, segments and -helical hydrophobic poly(L-leucine), L, segments to 
promote hydrogel self-assembly in aqueous media. We initially planned to prepare 
precursor copolypeptides of the general structure poly(L-methionine)170-b-poly(L-
leucine)n, M170Ln, with n ranging from 15 to 40; where the M segments would then be 
oxidized or alkylated to give the DCH forming copolypeptides. However, an issue we 
observed when attempting to polymerize the long M segments required for DCH (> 150 
residues) was that the resulting -helical M chains strongly aggregate in the reaction 
solvent hindering the uniform addition of Leu NCA monomers for block copolymer 
preparation49. Consequently, initial attempts to oxidize and alkylate Met residues in 
M170Ln resulted in samples unable to form hydrogels (vide infra). In order to address the 
problem of -helical M chain aggregation, we relied on previous observations that 
aggregation of hydrophobic helical polypeptides in organic solvents can be diminished 
by statistical addition of comonomers to disrupt side-chain packing24,49. Hence, we 
incorporated small amounts of a non-ionic, low hydrophobicity comonomer, L-alanine 
(Ala), during M segment polymerization in order to disrupt packing of -helical M chains 
and facilitate preparation of the desired diblock copolypeptide architectures53.   
 
Statistical copolymers of Ala NCA and Met NCA were prepared with target degrees of 
polymerization of ca. 100, where the Ala content was varied from 0 to 20 mol % 
(Scheme 1). The optimal Ala content was envisioned as the minimal amount required to 
disrupt polypeptide aggregation and allow efficient block copolypeptide synthesis. As 
expected, the Mm homopolymer containing no Ala formed an organogel in the reaction 
mixture due to chain aggregation. As the Ala content was increased, the poly(L-
methionine-stat-L-alanine)m, MAm, copolymers became more soluble in the reaction 
mixture, and eventually resulted in free-flowing viscous liquids at compositions 10 mol% 
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Ala and above (Scheme 1). It is noteworthy that the incorporation of 10 mol% Ala did 
not adversely affect the ability to obtain controlled NCA polymerizations required for 
synthesis of well-defined block copolypeptides (Supplementary Figure 1). Also, 
incorporation of 10 or 18 mol% Ala in MAm copolymers was found to have only minimal 
effect on the water solubility and disordered conformations of the corresponding 
oxidized poly(L-methionine sulfoxide-stat-L-alanine)m, M
OAm, samples compared to M
O 
homopolymer (Supplementary Figure 2)37,40.  Consequently, we selected MA 
copolymer segments containing 10 mol% Ala as optimized compositions for use in Met-
based DCH. 
 
Precursor diblock copolypeptides were then prepared containing MA segments ca. 170 
residues long, followed by poly(L-leucine), L, segments of different length: poly(L-
methionine0.9-stat-L-alanine0.1)170-b-poly(L-leucine)n, (MA)170Ln, with n ranging from ca. 
10 to 40 (Scheme 2). Previous studies on DCH showed that small variations of L 
segment length have a much greater effect on DCH mechanical properties compared to 
small variations in the hydrophilic segment length24,25. All copolymers were isolated in 
high yield with compositions that closely matched expected values (Table 1). The MA 
segment length was chosen based on values known, from previous studies on 
amphiphilic DCH24, to be sufficiently long to promote hydrogel formation. The L lengths 
were varied in order to study the role of hydrophobic composition on hydrogel formation 
and properties. Oxidation or methylation of these precursors using established 
methods33,40 was envisioned to yield the corresponding amphiphilic MO derivatives (i.e. 
DCHMO) and M
M derivatives (i.e. DCHMM), respectively, for evaluation as DCH (Scheme 
2). 
 
3.1.2. Synthesis of DCHMO and DCHMM 
Complete and selective oxidation of (MA)170Ln copolypeptides to the corresponding 
sulfoxide derivatives, (MOA)170Ln (i.e. DCHMO), was accomplished using tert-butyl 
hydroperoxide (Table 1, Supplementary Information NMR spectra). We had 
previously used hydrogen peroxide for this purpose with shorter Met containing 
segments, but found that this reagent is not completely selective for MetO formation 
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when longer, less soluble Met containing copolymers are oxidized. Small amounts of 
sulfone groups were observed to form with hydrogen peroxide (Supplementary Figure 
3), which can adversely affect DCHMO properties. As a different modification, selective 
methylation of (MA)170Ln copolypeptides to the corresponding S-methyl sulfonium 
derivatives, (MMA)170Ln (i.e. DCHMM), was accomplished using iodomethane, which gave 
the modified copolypeptides in excellent yields (Table 1, Supplementary Information 
NMR spectra). Both oxidation and methylation modifications of Met residues in these 
copolypeptides result in conversion of the fully hydrophobic (MA)170Ln precursors into 
amphiphilic copolymers with potential to self-assemble in water and form DCH. Both 
modifications also convert -helical MA segments in the copolymers into 
conformationally disordered MOA and MMA segments30. The modifications differ in that 
MOA chains are non-ionic and hydrophilic, while MMA chains are cationic and 
hydrophilic. 
 
3.1.3. Synthesis of DCHMOK 
To study how introduction of charged groups into DCHMO affects hydrogel properties we 
prepared a small series of samples where the Ala residues of DCHMO were replaced 
with L-lysine, Lys, residues. The Lys residues were expected to assist controlled 
synthesis of long Met rich segments in a manner similar to Ala, as described above. In 
addition, these residues, when protonated, will introduce cationic charges into the 
hydrophilic segments of DCHMO. Lys residues were introduced by copolymerization of 
different fractions of N-tert-butoxycarbonyl-L-Lysine NCA (Boc-Lys NCA), with Met 
NCA, followed by polymerization of the Leu block (Supplementary Scheme 1). 
Deprotection of the Lys residues using TFA, followed by selective oxidation of the Met 
residues gave the desired copolypeptides: poly(L-methionine sulfoxidex-stat-L-lysine-
HCly)170-b-poly(L-leucine)23, (M
O
xKy)170L23, with x:y = 0.90:0.10 (DCHMOK10) and 
0.85:0.15 (DCHMOK15) (Supplementary Scheme 1 and Supplementary Table 2). 
Copolymerization, subsequent deprotection and oxidation proceeded without issues, 
showing that another comonomer beside Ala can be used to prepare well-defined 
copolypeptides containing long Met rich segments. The introduction of charged Lys 
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residues into DCHMOK was expected to affect both physical and biological properties of 
these materials. 
 
3.2. Formulation and properties of Met-based DCH 
 
3.2.1. Preparation and rheological properties of DCHMO and DCHMM 
For initial evaluation, all DCHMO and DCHMM samples, as well as Ala lacking (M
O)170L23 
and (MM)170L24 control samples, were separately mixed with deionized (DI) water at 
concentrations ranging from 1.0 to 9.0 wt% (Table 2). These samples were briefly 
agitated and then let stand for 24h, whereupon they were visually examined 
(Supplementary Figure 4). At 1.0 wt%, all samples formed free-flowing, transparent 
fluids. As concentrations were increased, all DCHMO and DCHMM samples were 
observed to form hydrogels, except for those with the shortest L segments, (MOA)170L12 
and (MMA)170L12, which were both transparent fluids up to 9.0 wt%. DCHMM samples 
were generally found to form hydrogels at lower concentrations compared to analogous 
DCHMO samples of similar composition. For all DCHMO and DCHMM samples with L17 
segments or longer, hydrogel formation improved with both L segment length and 
sample concentration. However, in samples with longer L segment lengths and at 
higher concentrations, copolypeptide precipitation was also observed in these 
hydrogels. Hydrogel opacity was generally more pronounced in the DCHMM samples 
relative to DCHMO samples (Supplementary Figure 4). It is noteworthy that the Ala 
lacking (MO)170L23 and (M
M)170L24 samples were unable to form hydrogels 
(Supplementary Figure 5), except for (MM)170L24 that formed an opaque hydrogel at 9 
wt%. These results confirm the importance of copolymerization of Ala residues into the 
Met segments for DCH formation. 
 
To quantify hydrogel properties, oscillatory rheology studies were conducted on select 
DCHMO and DCHMM samples. For DCHMO samples at 5.0 wt% in DI water, hydrogel 
stiffness (G') was found to increase with L segment length up to L28, yet precipitation in 
samples with longer L segments reversed this trend (Figure 1A). Due to its desirable 
combination of hydrogel stiffness and minimal turbidity, (MOA)170L28 was chosen as an 
optimized DCHMO composition for further mechanical properties study. Preparation of 
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DCHMO using different concentrations of (M
OA)170L28 in DI water was found to be a 
convenient means to adjust hydrogel stiffness (Figure 1B). All samples formed clear 
elastic hydrogels (G' » G'' over a range of frequency, Figure 1C), and their stiffness was 
found to increase with higher copolypeptide concentrations. The lack of visible 
aggregates in these samples suggests that polymer chains were able to assemble into 
the desired structures even at high concentrations. The self-healing properties of 
DCHMO after mechanical breakdown were studied by repeatedly subjecting a 5.0 wt% 
(MOA)170L28 sample in DI water to high amplitude oscillatory strain, and then monitoring 
the recovery of elasticity over time by measuring G' at a much smaller strain amplitude 
(Figure 1D). The periods of high strain resulted in G' dropping by two orders of 
magnitude to below the level of G'', indicating the sample had become a viscous liquid. 
Upon switching to low strain, the sample self-healed to recover its elastic properties, 
with most of the original gel stiffness regained within the brief period (ca. 10 s) needed 
to switch between strain amplitudes. 
 
For DCHMM samples at 5.0 wt% in DI water, hydrogel stiffness (G') was also found to 
increase with L segment length up to L33, and then leveled off as sample precipitation 
occurred with longer L segments (Figure 2A). The increased hydrophilicity of the 
charged MM segments compared to non-ionic MO segments may be responsible for the 
significantly greater stiffness of these samples compared to DCHMO. For reasons similar 
to those stated for DCHMO, (M
MA)170L27 was chosen as an optimized DCHMM 
composition for further mechanical properties study. Preparation of this DCHMM at 
different concentrations in DI water was similarly found to conveniently adjust hydrogel 
stiffness (Figure 2B). All samples formed elastic hydrogels (G' » G'' over a range of 
frequency, Figure 2C) with stiffness that increased with higher copolypeptide 
concentrations. However, in contrast to DCHMO of similar composition, visible 
aggregates were observed at sample concentrations greater than 5.0 wt%. The 5.0 wt% 
(MMA)170L27 sample in DI water was also able to exhibit shear thinning and self-healing 
properties comparable to results observed above with DCHMO (Figure 2D). 
 
3.2.2. Effects of ionic media on DCHMO and DCHMM 
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Select DCHMO and DCHMM samples ((M
OA)170L24 and (M
MA)170L23) were also prepared 
in different aqueous media (Figure 3). We used these samples, containing L23/24 
hydrophobic segments, since their mechanical properties were closest to those of 
hydrogel formulations we have found to be useful for CNS applications. Samples were 
prepared at 5 wt% in either DI water, 1x PBS buffer, or DMEM cell culture medium, and 
their rheological behavior studied. Mechanical properties of the non-ionic DCHMO 
formulations were minimally affected by the ions present in media (Figure 3A, B), 
allowing for predictable mechanical behavior under different solution conditions. 
Conversely, mechanical properties of the cationic DCHMM formulations were strongly 
affected by the ions present in media (Figure 3C,D), with hydrogel stiffness (G') 
decreasing significantly in the presence of ions compared to DI water. Notably, different 
media (PBS and DMEM) had similar effects on DCHMM properties, and the DCHMM in 
these media remained hydrogels with stiffness comparable to analogous DCHMO 
formulations. Another difference observed between DCHMO and DCHMM formulations 
was their breakdown at elevated percent strain. The DCHMM formulations were found to 
be more brittle than analogous DCHMO formulations, especially in ionic media, where 
the DCHMM samples were observed to breakdown at relatively low percent strain 
(Figure 3B, D). As shown above, at very high percent strains (ca. > 1000%), both 
DCHMO and DCHMM will break down into liquids.   
 
3.2.3. Rheological properties of DCHMOK 
The Lys containing samples DCHMOK10 and DCHMOK15 were mixed with DI water 
or 1x PBS to give concentrations of 5.0 wt% and were found to form hydrogels in both 
media after standing for 24h. In DI water, DCHMOK10 and DCHMOK15 formed hydrogels 
with stiffness (G') intermediate between those of DCHMO and DCHMM at similar 
compositions (Figure 4, Supplementary Figure 6). Hydrogel stiffness was found to 
increase with increased ionic residue content in the DCH, where even 15 mol% charged 
residues in the hydrophilic DCH segments was sufficient to result in hydrogel stiffness 
comparable to that obtained with the fully charged segments in DCHMM. Increased 
charged residue content also significantly impacted hydrogel salt stability, where 
DCHMOK15 was found to weaken significantly in PBS, similar to DCHMM. DCHMOK10 
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behaved more like DCHMO in PBS, where hydrogel stiffness was even found to increase 
in ionic media. From these observations, it can be seen that small variations in charged 
residue content in DCHMOK can result in substantial effects on both hydrogel stiffness 
and salt stability. 
 
3.3. NSPC viability in Met-based DCH 
For CNS cell transplantation a cell compatible biomaterial vehicle that promotes 
negligible cytotoxicity is required. To test the cell viability of Met-based DCH materials 
we derived a passagable, adherent neural stem/progenitor cell (NSPC) line from mouse 
embryonic stem cells (ESC) using previously validated and published protocols 
(Supplementary Figure 7A)55-57. The use of an ESC derived NSPC line overcame 
many of the quality and reproducibility limitations associated with using primary cells 
harvested from fetal or post-natal tissue that we have employed in our previous 
studies28,53. Before encapsulating cells in DCH formulations we confirmed NSPC 
derivation by qPCR and immunohistochemical analysis (Supplementary Figure 7B). 
The adherent NSPC line showed characteristic increased expression of canonical 
neural stem cell genes (Nestin, Sox2, Sox9, Olig2) as well as a de-enrichment of classic 
ES identifiers Nanog and Oct4 (Supplementary Figure 7B). Immunocytochemical 
staining further confirmed robust protein expression of the same canonical neural stem 
cell markers in our NSPC line (Supplementary Figure 7C, D). The NSPC used in this 
study contain a hemagglutinin (HA) tag on ribosomal protein L22, a component of the 
60S ribosomal subunit (referred to here as Ribotag). This Ribotag can be used as an in 
vivo reporter to distinguish transplanted NSPCs from host cells by 
immunohistochemistry as well as allowing for cell specific translating mRNA extraction 
from whole tissue54. We confirmed 100% expression of the HA Ribotag in every cell in 
the NSPC line by immunocytochemistry (Supplementary Figure 7E). The NSPC line 
showed negligible expression of the pan astrocyte marker GFAP and pan neuronal 
marker TUJ-1 by immunohistochemical staining under regular culture conditions. 
However, NSPC showed a competency to differentiate into these two cell types upon 
exposure to fetal bovine serum (FBS) enriched media consistent with previous 
characterization of similar NSPC lines (Supplementary Figure 7E1)
56,58. Before and 
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after neuronal or astrocyte differentiation the cells maintained robust HA expression that 
filled the entire cell cytoplasm (Supplementary Figure 7E2).  
 
To evaluate the relative cell compatibility of the various Met-based DCH vehicles we 
encapsulated NSPC within DCHMO, DCHMM, DCHMOK10 and DCHMOK15 formulations and 
incubated the cell-hydrogel construct on top of beds of cell media enriched agarose gels 
for 24 hours. Specific copolypeptide compositions used in these and all subsequent 
biological studies were (MOA)170L24, (M
MA)170L23, (M
O
0.90K0.10)170L23, and (M
O
0.85K0.15)170L23.  
Cell viability was determined by analyzing the distribution of live and dead cells using 
calcein AM and ethidium homodimer-1 staining. The non-ionic DCHMO
 showed excellent 
NSPC viability for all formulations tested from 2 to 5 wt% copolypeptide.  The negligible 
cytotoxicity for DCHMO over the 24 hour period was equivalent to that observed for the 
positive control of cells alone in media (Figure 5A, B, D). By contrast DCHMM 
formulations containing positively charged sulfonium functional groups demonstrated 
substantial NSPC cytotoxicity which was equivalent to the cell death observed for 
DCHK, another cationic copolypeptide hydrogel we have shown previously to be 
cytotoxic towards various suspended cells28,53 (Figure 5A, D). The Lys containing 
hydrogels DCHMOK10 and DCHMOK15 showed reduced NSPC viability compared to 
DCHMO with cytotoxicity increasing in a Lys concentration dependent manner. 
Specifically, DCHMOK10 showed 80.7% NSPC viability while DCHMOK15 demonstrated 
comparable cytotoxicity to that observed for DCHMM and DCHK suggesting this to be the 
minimum Lys content required within DCH polypeptides for complete lysis of suspended 
cells.  (Figure 5C). 
 
3.4. NSPC adhesion to Met-based DCH 
Cell-biomaterial interactions may influence NSPC transplant outcomes59. Since MO 
polypeptides have previously been demonstrated to be non-fouling, bioinert substrates 
for cells in vitro41, we sought to evaluate NSPC interactions with Met-based DCH. To 
achieve this, we assessed the ability of NSPC to adhere to substrates coated with the 
various Met-based DCH and compared and normalized them to a standard cell 
adhesion promoting biomolecule, gelatin, which is used widely across adherent in vitro 
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assays. The use of 70% ethanol solutions of Met-based DCH ensured robust 
copolypeptide coating to either hydrophobic siliconized glass slides or hydrophobic 
untreated polystyrene. Calcein AM staining after vigorous washing to remove non-
adhered cells was used to quantify the amount of viable adhered cells to each 
substrate. At 24 hours after seeding NSPC in FBS enriched media, DCHMO showed 
negligible NSPC adhesion (0.23% of the gelatin coated substrate cell number) and 
instead led to significant cell aggregation resulting in large clumps of cells that were 
hundreds of µm in diameter (Figure 6A, B, Supplementary Figure 8). The minimal cell 
adhesion was equivalent to that achieved for the amphiphilic PEG based negative 
control. By contrast, the DCHMM with 63.2% adhered cells was comparable to that seen 
for the positively charged Lys based DCHK (74.3%) with cells displaying a characteristic 
adherent, flattened morphology by brightfield microscopy (Figure 6A, B). Introduction of 
cationic charge within DCHMO via replacement of Ala with Lys residues (i.e. DCHMOK10, 
DCHMOK15) increased the cellular interactions with the copolypeptide chains and 
consequently increased cell adhesion to coated substrates. Cell adhesion increased in 
a Lys concentration dependent manner with DCHMOK10 maintaining 30.3% cell adhesion 
while DCHMOK15 showing 76.7% cell adhesion. Cells on surfaces of DCHMOK10 adhered 
as small multi-cellular aggregates that were smaller in size than those seen in the 
DCHMO samples with some flattened adherent cells visible at the margins of the 
aggregate (Figure 6B). The extent of cell adhesion for DCHMOK15 was comparable to 
DCHK and DCHMM suggesting that the charge distribution on the DCHMOK15 represented 
the minimum amount of net charge needed along DCH copolypeptide chains to promote 
significant interaction with NSPC. Interestingly, the cell adhesion data was inversely 
related to the observed cell viability results articulated above when NSPC were 
suspended within the same DCH formulation. These data suggest that non-specific 
cationic charge based cell interactions can robustly encourage NSPC to adhere to a 
constrained two dimensional substrate with negligible cytotoxicity. However, when the 
cells are immersed within DCH containing the same hydrophilic chains, the strength and 
concentration of these polymer-cell interactions, which are less constrained in space 
and undergo dynamic movement around the encapsulated NSPC, results in cell 
membrane disruption and/or lysis causing cell death.  
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3.5. NSPC differentiation with Met Based DCH 
Physical interactions of stem cells with the extracellular matrix environment are principal 
determinants of cell fate decision making60. Similarly, NSPC differentiation outcomes 
upon transplantation in the CNS are also influenced by their interactions with 
biomaterial carriers61, as well as with host tissue elements. To understand how cellular 
interactions with the Met-based DCH influence NSPC cell fate outcomes we devised an 
assay to evaluate NSPC differentiation on DCH coated substrates. Towards replicating 
the environment the transplanted NSPC would experience in vivo within the context of 
CNS injury we cultured NSPC in media containing 10% FBS along with standard NSPC 
supplements (EGF, FGF and B27). NPSC differentiation was evaluated on substrates of 
DCHMO, DCHMM or gelatin for 48 hours. After 48 hours in this serum rich environment 
the cells were transferred to unsupplemented conditions on gelatin substrates to 
evaluate the spontaneous differentiation of these cells following FBS treatment (Figure 
7A). NSPC differentiation was significantly influenced by the chemical properties of the 
substrate (Figure 7B, C, Supplementary Figure 9). NSPC cultured on gelatin during 
the 48 hours of FBS exposure exhibited a significantly increased density of GFAP 
positive cells normalized to HA positive cell signal (a measure of total surface area 
occupied by cells on the substrate) compared to the DCHMO and DCHMM coated 
substrates. By contrast, a predominately neuronal differentiation phenotype (as 
measured by TUJ-1 positive cell density) was observed on the DCHMM coated 
substrate. The DCHMO coated surface, unlike the two cell adhesive substrates, exhibited 
no clear dominant differentiated cell type and showed an overall reduced extent of total 
cell differentiation that was approximately half of that observed on the gelatin surface 
(Figure 7C). To understand why the DCHMM coated substrate showed a preferred 
neuronal differentiation profile compared to gelatin, we compared NSPC phenotypes 
immediately after FBS exposure by immunocytochemistry (Figure 7D). While gelatin 
coated substrates showed a dense field of GFAP and TUJ-1 positive cells at the 
conclusion of FBS treatment, cells on DCHMM expressed exclusively TUJ-1 that was 
distributed diffusely throughout the cell cytoplasm rather than being organized in 
ordered, filamentous cytoskeletal structures that is characteristic of cultured neurons. 
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NSPC cultured on DCHMM were also less dense in number and exhibited a larger and 
more flattened cell morphology with extensive filopodia projections that varied in shape 
and size between different cells throughout the surface. The relative strength of the cell 
interactions with the DCHMM substrate was further characterized by assessing the 
number of cells that remained on the surface following a trypsinization procedure 
(Figure 7E). While complete cell removal off of the gelatin surface was achieved 
following trypsinization, approximately 12% viable cells remained on DCHMM following 
the same procedure. This residual adhered cell number is likely an under estimate of 
the total remaining cells after trypsinization as this procedure can be considerably 
cytotoxic to persistently adhered cells and our outcome measure (Calcien AM staining) 
only identified live, viable cells. Regardless of the exact percentage of remaining cells, 
the relatively high number of residual cells comparatively to the gelatin substrate 
coupled with the flattened, irregular cell morphology suggests a particularly strong cell 
interaction with DCHMM. Additionally, qPCR was performed on cells collected at the end 
of the 48 hour FBS treatment to evaluate the effect of surface properties on the gene 
expression of neural stem cell and neural cell type specific markers (Figure 7F). In line 
with the immunocytochemistry data, cells cultured on DCHMO showed a more preserved 
progenitor-like gene profile upon FBS exposure with canonical neural stem cell genes 
Nestin and Sox9 being less down regulated in this group compared to cells cultured on 
the adhesive substrates. Interestingly, GFAP gene expression was highest for DCHMO 
over all other groups, while GFAP was also significantly expressed by cells on DCHMM. 
The mismatch between GFAP mRNA abundance and protein expression levels 
measured by immunocytochemistry across the different treatments suggests that the 
physical substrate and how cells interact with it may influence important cellular 
functions such as mRNA post transcriptional modifications, protein synthesis and 
cytoskeletal protein assembly. Overall, these data suggest that the non-adhesive 
DCHMO preserves the multipotency of NSPC in serum rich environments compared to 
adhesive materials. This unique biological property of DCHMO may prove to be useful for 
ensuring robust survival and integration of transplanted NSPC within CNS injury 
microenvironments.   
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3.6. In vivo NSPC transplantation using Met-based DCH 
To evaluate the utility of Met-based DCH as biomaterial carriers for CNS transplantation 
we first injected empty DCHMO into the uninjured mouse striatum and compared the 
induced foreign body response to a saline control. DCHMO alone caused minimal host 
CNS tissue disruption. Specifically, the proximal neuronal survival as well as the extent 
and magnitude of the reactive astroglial response for the DCHMO was comparable to 
that of the saline injection (Supplementary Figure 10). Next, we transplanted NSPC 
encapsulated within DCHMO into the uninjured mouse striatum. The NSPC suspended 
uniformly within DCHMO and did not sediment or aggregate throughout the entire 
duration of both the glass pipette loading and the slow controlled injection procedure, 
which was similar to that seen for our previously studied formulations28. Gene profiling 
of NSPC suspended within DCHMO recovered from the un-injected fraction of 
biomaterial at 6 hours after initial cell loading showed negligible change in gene 
expression of canonical neural stem cell genes for the injected cells compared to the in 
vitro cultured NSPC line (Supplementary Figure 11). At 4 weeks after transplantation 
NSPC injected brains were analyzed by immunohistochemistry (Figure 8). Injected 
NSPC loaded in DCHMO formed an obvious and focal deposit within host tissue that 
persisted over the 4 week observation period. Transplanted cells as well as any 
potential progeny were readily identified by HA immunohistochemical staining. 
Transplanted cells were observed within the hydrogel as multicellular neurosphere 
aggregates that had adhered to the margins of the hydrogel deposit and subsequently 
integrated with host tissue (Figure 8). Within host tissue, transplanted cells were 
constrained within a tissue volume region that was within several hundred µm of the 
border of the hydrogel deposit (Figure 8). Thus the use of the DCHMO vehicle prevented 
long distance migration of transplanted cells away from the injection zone to other brain 
regions. Essentially all transplanted cells expressed GFAP robustly by 4 weeks but also 
maintained widespread expression of the canonical neural stem cell markers SOX9 
(Figure 8A, B), SOX2 (Figure 8C) and NESTIN (Figure 8D) characteristic of an 
immature astroglial phenotype58. This extensive GFAP expression represented an 
upregulation of this astroglial marker compared with the NSPC at the time of 
transplantation. Grafted cells were uniformly negative for the neuronal marker TUJ-1 
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(Supplementary Figure 12). By four weeks the numerous transplanted cells that had 
integrated into the adjacent host tissue had adopted distinct, individual cellular domains 
reminiscent of normal host astroglial cells62 (Figure 8B).   
 
Immunohistochemical evaluation revealed that host neurons (Figure 9) and host 
astrocytes (Figure 10) persisted with normal density and viability at the edge of the 
NSPC graft margin. HA positive transplanted cells with their GFAP positive cellular 
processes integrated into fields of, and interacted directly with, host NEUN positive 
neurons (Figure 9A, B). In addition to direct interactions with neuronal somas, grafted 
cells showed a capacity to act as cellular substrates to attract and support the growth of 
host axons. Specifically, using Neurofilament M (NFM) to label host axons, we observed 
that the transplanted NSPC functioned as cellular bridges permitting regrowth of 
meandering host axons into the DCHMO deposit site (Figure 9C, D). Such a function is 
consistent with the role host immature astroglia play during CNS development to 
support and guide axon growth63 and may be important for promoting regeneration of 
damaged axons in the context of CNS injury26,28,64. While the HA positive transplanted 
cells expressed high levels of GFAP, they did not express the more mature astrocyte 
marker ALDH1L1 (Figure 10A, C), further supporting the notion that these cells had 
persisted as immature astroglial cells throughout the 4 weeks of residence in the 
uninjured CNS56,65. Some HA positive cells expressed an alternative but less mature 
astrocyte marker, S100β, suggesting the transplanted cells may be progressing through 
astrocyte maturation. However, S100β expression was not widespread among all 
transplanted cells (Figure10B). Despite their immature phenotype, grafted cells were 
observed to interact directly, and intermingle, with host astrocytes (Figure 10C). Host 
astrocytes were also observed to migrate into the persistent DCHMO deposit site that 
contained a high density of grafted cells (Figure 10A, B), creating a fluid transition of 
intermingled host and grafted astroglia at the margins of the graft deposit. Furthermore, 
at the margins of the DCHMO deposit there was no evidence of host astrocyte scarring 
or walling off of the NSPC-hydrogel implant, while host astrocytes in close proximity of 
the DCH deposit margin were only mildly reactive and maintained discrete individual 
cellular domains. Overall, these findings suggest that NSPC transplanted in DCHMO can 
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provide cells that integrate well with receptive host neural tissue and serve supportive 
functions that may be useful for neural repair.   
 
4. Discussion 
In this study, we developed a novel biomaterial platform focused on the post-
polymerization modification of Met-based copolypeptides. These new materials show 
diverse and tunable physiochemical and biological properties with some formulations 
demonstrating utility as vehicles for aiding the in vivo transplantation of NSPC in the 
CNS. Our findings have implications at several levels, including (i) the technical 
development of non-ionic biomaterial vehicles for NSPC delivery; (ii) the influence of 
Met-based DCH on NSPC survival and differentiation; and (iii) the potential of Met-
based DCH for NSPC transplantation into injured CNS.  
 
4.1. Technical considerations regarding development of non-ionic, Met-based 
DCH 
We have shown previously that ionic DCH such as DCHK are useful vehicles for delivery 
of both small molecule and protein biologically active agents into mouse CNS tissues in 
vivo. In particular, the modular design of DCH permits fine tuning of their physical 
characteristics for specific applications, and their synthetic nature allows for scalable 
synthesis and reproducible formulation. An initial effort to prepare non-ionic DCH for 
encapsulation of cells in vitro and their grafting into tissues in vivo used synthetic 
methods relying on unnatural amino acid components that limited scalability and 
prohibited incorporation of functionality into these DCH28. To correct these limitations, 
we envisioned Met-based DCH as a versatile platform of precursor copolypeptides that 
could be selectively modified at Met residues using a variety of efficient procedures to 
give DCH with different physical and biological properties. Initial targets for evaluation 
were non-ionic DCHMO and a model cationic derivative, DCHMM. 
 
Aggregation of M polymers during synthesis was an initial hurdle that was overcome by 
judicious addition of comonomers, i.e. Ala and Lys, which were found to disrupt helical 
side-chain packing of M segments and thus enabling controlled synthesis of Met DCH 
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precursors. The need to incorporate comonomers in the M segments was found to be 
advantageous, as they can provide additional means to fine tune DCH properties. Ala 
residues were found to act as inert diluents that imparted no adverse effects on the 
properties of the modified M segments. Incorporation of Lys residues was found to be a 
useful means to introduce controllable quantities of charged residues into MO segments. 
Another potentially useful feature of these Met DCH precursors is that some of the Met 
or Lys residues can also serve as sites for selective conjugation of bioactive molecules 
or fluorescent probes for added functionality30.  
 
Straightforward modification of Met DCH precursors using literature methods gave non-
ionic DCHMO and cationic DCHMM with near quantitative levels of functionalization in 
excellent yields. Both DCHMO and DCHMM of different compositions formed hydrogels 
over a range of concentrations in DI water. At equivalent compositions and 
concentrations, DCHMO formed inherently weaker hydrogels compared to DCHMM, which 
is likely due to the greater water solubility, and electrostatic repulsions in the cationic 
MMA segments compared to non-ionic MOA segments. However, DCHMO were found to 
be more ductile and stable to ionic media compared to DCHMM, such that hydrogel 
stiffness of comparable samples was very similar in ionic media. This finding is 
important since both of these hydrogels will be used primarily in ionic media for all 
biological studies. Overall, both DCHMO and DCHMM were found to possess desirable 
physical properties for evaluation as vehicles in CNS applications, including injectability 
and tunable stiffness and surface functionality. We were particularly interested to study 
how variation of charge content in DCHMO, DCHMOK and DCHMM affects how these 
hydrogels interact with cells. 
 
4.2. The influence of Met-based DCH on NSPC survival and differentiation 
Cues from the extracellular environment both within in vitro culture conditions and 
neural tissue niches in vivo shape the differentiation decision making of NSPC. Detailed 
experimental information pertaining to the relative importance of various stimuli, 
including the physiochemical properties of biomaterial carriers, on NSPC differentiation 
is beginning to emerge22. In particular, properties such as mechanical stiffness and 
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biomaterial degradability have been extensively studied63. Here, by leveraging the 
physiochemical tunablity of Met-based DCH through various post-polymerization 
modifications, we characterized and optimized the effect of biomaterial surface 
chemistry on NSPC differentiation. DCHMO by virtue of its non-fouling sulfoxide 
functionality showed a remarkable preservation of neural stemness in a serum rich in 
vitro environment compared to adhesive substrates DCHMM and Gelatin. To improve 
survival of NSPC upon transplantation in traumatic CNS lesions a biomaterial carrier 
capable of keeping the cells in a more robust immature state for longer upon grafting 
would be advantageous.   
 
In addition to the development of a novel hydrogel we also describe here for the first 
time the derivation of a Ribotag NSPC line. Ribotag is a cell specific mRNA isolation 
technique from whole tissue that has gained in popularity over the past several 
years26,54,66. This paper describes and validates the derivation of the Ribotag NSPC line 
from transgenic ESC and demonstrates the preservation of detectable HA positive 
ribosomes within cells throughout the various stages of NSPC development and 
differentiation. While not explored here, the goal for the use of these cells in future 
experiments is to perform in vivo transplant cell specific genetic evaluation in the 
context of CNS injury. This paper represents a first step towards this goal by 
demonstrating the ability to: (i) detect HA positive NSPC and their progeny by 
immunohistochemistry in vitro and in whole tissue after grafting in vivo, as well as (ii) 
characterize the robustness of Ribotag mRNA expression within cells at various stages 
of development both in vitro and in vivo such that it could be used as a housekeeping 
gene to normalize gene expression data. Furthermore, the robust and persistent 
expression of Ribotag by NSPC and their progeny in vivo, provides a means of selective 
isolation of transcribed mRNA specifically from grafted cells for analysis of changes in 
their transcriptional profiles at different times after transplantation and under different 
grafting conditions. Given the interesting findings pertaining to the variation in NSPC 
differentiation in vitro as a function of material surface properties and exposure to 
different morphogens, future experiments using these cells can be directed towards 
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obtaining a detailed understanding of the effect of hydrogel carrier properties and 
effects of co-delivery of regulatory molecules on NSPC differentiation in vivo. 
 
4.3. The potential of Met-based DCH for NSPC transplantation into CNS injury 
In the context of CNS insults such as spinal cord injury, traumatic brain injury or stroke 
damage of neural tissue results in a biologically conserved wound healing response that 
leads to the formation of non-neural tissue (NNT) lesions67,68. NNT lesions hinder 
endogenous recovery/regeneration of damaged neural circuitry as this tissue is 
permanently devoid of functioning neurons and glia. Grafting of NSPC has emerged as 
a potential therapy for CNS injury by repopulating NNT lesions with a neural cell milieu 
that can provide both the trophic support and physical substrates necessary to aid the 
axon regeneration required to reestablish functioning circuits68. In this study we showed 
that transplanted NSPC, in the absence of differentiation directing morphogens, adopt 
immature astroglial phenotypes at 4 weeks that were capable of interacting with host 
astrocytes and neurons as well as acting as a cellular substrate for regrowing axons 
locally in the vicinity of the injected hydrogel. DCHMO aided in keeping transplanted cells 
local to the injection site but still permitted comprehensive integration with host neural 
tissue. Transplanted cells adopted an immature astroglial cell state (as demonstrated by 
robust GFAP, SOX2, SOX9 and NESTIN expression) and no transplanted cells 
expressed the pan-neuronal maker TUJ-1 or the mature astrocyte marker ALDH1L1. 
These results indicate that, in the absence of co-delivery of differentiation directing 
morphogens, these cells do not undergo any significant spontaneous differentiation and 
maturation in vivo, at least up to 4 weeks. We have previously shown that DCH vehicles 
can be used to controllably delivery a variety of small molecule and protein based drugs 
to the CNS26. Therefore, future studies will explore using DCHMO to co-deliver both 
NSPC and specific bioactive morphogens to facilitate specific in vivo directed 
differentiation and maturation of transplanted cells. 
 
5. Conclusion 
In this study we developed a new Met-based DCH platform that overcame several 
synthetic limitations associated with previous formulations and demonstrated tunable 
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physiochemical and biological properties. Met-based DCH also offer considerable 
flexibility in terms of converting Met residues to different functional derivatives, as well 
as the ability to incorporate different amino acid comonomers into their hydrophilic 
segments. The non-ionic DCHMO formulations were found to be advantageous for cell 
transplantation applications since they possess: (i) favorable cytocompatibility, (ii) cell 
non-fouling properties, and (iii) an ability to better persevere NSPC stemness in serum 
rich environments compared to adhesive substrates. DCHMO facilitated local injection 
and retention of NSPC and its progeny in the uninjured mouse CNS. In the absence of 
added morphogens, transplanted cells maintained an immature astroglial phenotype at 
4 weeks that favorably interacted with host neural tissue and acted as a cellular 
substrate to aid regeneration of host-derived damaged or sprouted axons. These 
findings suggest that DCHMO is a suitable hydrogel carrier for neural stem cell 
transplantation applications and warrants further investigation as a therapeutic tool in 
CNS injury studies.  
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SCHEME 1 
 
 
 
 
 
Scheme 1: Synthesis of MA statistical copolymers. Copolymerization of L-methionine NCA and 
L-alanine NCA with Co(PMe3)4 initiator to give MA copolymers in THF with a total NCA concentration 
of 50 mg/mL and total monomer to initiator ratio of 60:1. Images of reaction mixtures after complete 
monomer consumption were taken 30 seconds after tilting the vial to evaluate solution viscosity. A) 
M:A molar ratio = 100:0. B) M:A molar ratio = 97.5:2.5. C) M:A molar ratio = 95:5. D) M:A molar ratio 
= 90:10. E) M:A molar ratio = 80:20. F) Reaction scheme for the copolymerization of L-methionine 
and L-alanine NCAs. x = mole fraction M. y = mole fraction A. m = degree of polymerization.  
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SCHEME 2 
 
 
 
 
 
Scheme 2: Synthesis of modified methionine amphiphilic diblock copolypeptides: cationic 
(MMA)170Ln  (DCHMM) and nonionic (M
OA)170Ln (DCHMO). Reaction conditions: (A)MeI, H2O, 20 ºC, 5 d 
; (B) TBHP, CSA, H2O, 20 ºC 1 d. 
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TABLE 1 
 
 
Table 1: Copolymerization data for DCHMO and DCHMM. 
aDispersity values for (MA)m 
copolypeptides were determined by GPC/LS. bAmino acid compositions of diblock copolypeptides 
were determined by 1H NMR integrations. Degree of polymerization of initial (MA)m segment was 
determined by end-group analysis using 1H NMR. cOverall isolated yield of diblock copolypeptide 
after oxidation or alkylation of methionine residues. dPercent functionalization after oxidation or 
alkylation reactions was determined using 1H NMR. 
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 Sample Mw/Mna Compositionb 
 
Yieldc  
(%) 
Functional 
Modificationd (%) 
D
C
H
M
O
 
MO170L23 1.28 MO176L23 88.1 100 
(MOA)170L12 1.44 (MOA)175L12 84.3 100 
(MOA)170L17 1.44 (MOA)164L17 85.2 100 
(MOA)170L24 1.44 (MOA)171L24 84.6 100 
(MOA)170L28 1.36 (MOA)167L28 84.1 100 
(MOA)170L33 1.33 (MOA)172L33 85.6 100 
(MOA)170L39 1.41 (MOA)164L39 86.5 100 
D
C
H
M
M
 
MM170L24 1.34 MM176L24 88.7 98 
(MMA)170L12 1.44 (MMA)179L12 90.3 99 
(MMA)170L17 1.35 (MMA)179L17 88.8 99 
(MMA)170L23 1.33 (MMA)178L23 93.4 99 
(MMA)170L27 1.34 (MMA)165L27 92.7 99 
(MMA)170L33 1.29 (MMA)165L33 93.4 99 
(MMA)170L36 1.25 (MMA)167L36 93.4 98 
 
TABLE 2 
 
 
 
 
 
Table 2: Hydrogel formation of DCHMO and DCHMM. Properties of DCHMO and DCHMM samples 
after dispersion in DI H2O at different concentrations. Samples were found to be either clear liquids 
(gray box), clear hydrogels (white box), or opaque hydrogels (*). 
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Sample 1 wt % 2 wt % 3 wt % 5 wt % 7 wt % 9 wt %
D
C
H
M
O
MO170L23
(MOA)170L12
(MOA)170L17
(MOA)170L24
(MOA)170L28
(MOA)170L33 * * *
(MOA)170L39 * * * *
D
C
H
M
M
MM170L24 *
(MMA)170L12
(MMA)170L17
(MMA)170L23 * *
(MMA)170L27 * * *
(MMA)170L33 * * * *
(MMA)170L36 * * * *
FIGURE 1 
 
 
 
 
 
Figure 1: DCHMO mechanical properties evaluated by dynamic rheology. A) Storage 
modulus, Gʹ (Pa, black) and loss modulus, Gʺ (Pa, white) for (MOA)170Ln samples of different 
hydrophobic segment lengths (n = 12, 17, 24, 28, 33, and 39). All samples (5 wt %) were prepared in 
DI water at 25 ºC. B) Gʹ (Pa, black) and Gʺ (Pa, white) for (MOA)170L28 at different concentrations in DI 
water at 25 ºC. For A) and B) all Gʹ and Gʺ values were measured at an angular frequency of 10 rad/s 
and a percent strain of 0.5. Error bars represent the standard deviation for n = 3. C) Gʹ (Pa, filled 
squares) and Gʺ (Pa, open squares) for (MOA)170L28 at 5 wt % in DI water. Gʹ and Gʺ values were 
measured over an angular frequency range of 0.1 to 100 rad/s at a percent strain of 0.5. D) Recovery 
of a 5 wt % (MOA)170L28 hydrogel in DI water over time (Gʹ, filled squares; Gʺ, open squares) after 
application of stepwise large-amplitude oscillatory breakdown (gray area, percent strain of 1000 at 10 
rad/s for 120 s) followed by low-amplitude linear recovery (white area, percent strain of 0.5 at 10 rad/s 
for 300 s).  
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Figure 2: DCHMM mechanical properties evaluated by dynamic rheology. A) Storage 
modulus, Gʹ (Pa, black) and loss modulus, Gʺ (Pa, white) for (MMA)170Ln samples of different 
hydrophobic segment lengths (n = 12, 17, 23, 27, 33, and 36).  All samples (5 wt %) were prepared in 
DI water at 25 ºC. B) Gʹ (Pa, black) and Gʺ (Pa, white) for (MMA)170L27 at different concentrations in 
DI water at 25 ºC. For A) and B) all Gʹ and Gʺ values were measured at an angular frequency of 10 
rad/s and a percent strain of 0.5. Error bars represent the standard deviation for n = 3. C) Gʹ (Pa, 
filled squares) and Gʺ (Pa, open squares) for (MMA)170L27 at 5 wt % in DI water. Gʹ and Gʺ values 
were measured over an angular frequency range of 0.1 to 100 rad/s at a percent strain of 0.5. D) 
Recovery of a 5 wt % (MMA)170L27 hydrogel in DI water over time (Gʹ, filled squares; Gʺ, open 
squares) after application of stepwise large-amplitude oscillatory breakdown (gray area, percent 
strain of 1000 at 10 rad/s for 120 s) followed by low-amplitude linear recovery (white area, percent 
strain of 0.5 at 10 rad/s for 300 s). 
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Figure 3: Effects of ionic media on DCH mechanical properties. DCHMO and DCHMM properties 
in DI water (squares), 1x PBS (circles), or DMEM (triangles). A) Storage modulus, Gʹ (Pa, filled 
symbols), and loss modulus, Gʺ (Pa, open symbols) versus frequency for 5 wt % (MOA)170L24 at 25 ºC 
in different media. B) Gʹ (Pa, filled symbols), and Gʺ (Pa, open symbols) versus percent strain for 5 wt 
% (MOA)170L24 at 25 ºC in different media. C) Gʹ (Pa, filled symbols), and Gʺ (Pa, open symbols) 
versus frequency for 5 wt % (MMA)170L23 at 25 ºC in different media. D) Gʹ (Pa, filled symbols), and Gʺ 
(Pa, open symbols) versus percent strain for 5 wt % (MMA)170L23 at 25 ºC in different media. For A) 
and C) Gʹ and Gʺ values were measured over an angular frequency of 0.1 to 100 rad/s at a percent 
strain of 0.5. For B) and D) Gʹ and Gʺ values were measured at an angular frequency of 10 rad/s over 
a percent strain of 0.1 to 100. 
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Figure 4: Effect of amino acid composition on DCH mechanical properties. Comparison of 
mechanical properties for DCHMM ((M
MA)170L23), DCHMO ((M
OA)170L24), DCHMOK10 ((M
O
0.90K0.10)170L23), 
and DCHMOK15 ((M
O
0.85K0.15)170L23) hydrogels. Hydrogels were prepared in either DI water (black bars) 
or 1x PBS (gray bars) at 5 wt %. Storage modulus Gʹ (Pa, filled bars) and loss modulus Gʺ (Pa, open 
bars) were measured at an angular frequency of 10 rad/s and a percent strain of 0.5 at 25 ºC. Error 
bars represent the standard deviations for n = 3. 
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Figure 5: NSPC viability in Met based DCH. A-C) Quantification of cell viability of NSPCs in 
hydrogels demonstrates that DCHMO is non-cytotoxic towards suspended NSPC across 2-5 wt% while 
cationic polypeptides are cytotoxic in a charge density dependent manner. D) Images of Calcein AM 
(Green - Live cell marker) and ethidium homodimer-1 (Red - dead cell marker) staining for NSPCs in 
various hydrogel formulations. Scale bar: 100 µm. Error bars are standard deviation of n = 15. 
Statistical tests: One-way Anova in B) and Welch's t-test in A) & C) were applied for comparison of 
means. P-values: * < 0.002 and ** < 0.0001.   
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Figure 6: NSPC adhesion to Met based DCH. Untreated polystrene 96 well plates or 
hydrophobic glass slides were modified with different samples followed by seeding of NSPC. A) 
Quantification of NSPC attachment, as measured by fluorescent microplate measurements of Calcein 
AM staining, demonstrates the non-fouling properties of DCHMO and the effect of polypeptide cationic 
charge on cell adhesion. Error bars are standard error of n = 12. Welch's t-tests were applied for the 
comparisons of individual DCH means compared to each other or compared to the Gelatin control. P-
values: *< 0.003; **<0.002; ***< 0.0024. B) Brightfield microscope images of live NSPC on 
polypeptide coated hydrophobic glass substrates. NSPC seeded on DCHMO do not adhere to the 
surface and instead form large multicellular aggregates. Scale bar: 100µm.   
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Figure 7: NSPC differentiation with Met Based DCH. A) Schematic outlining the in vitro culture 
assay to evaluate NSPC differentiation on various coated substrates. B) Immuno-histochemical 
staining of pan neuronal (TUJ-1-Green) and astrocyte (GFAP-Red) as well as whole cell staining by 
HA to evaluate NSPC differentiation on DCHMO, DCHMM, and Gelatin (Scale bar: 50µm).  C) 
Quantification of Immunohistochemical staining for the different substrates reveals that DCHMO 
promotes preserved NSPC multipotency. (n=28-30 images per group from 5 unique slides, error bars 
are represented as standard error or means. * P-value < 0.001). D) Immunohistochemical staining of 
TUJ-1 and GFAP on DCHMM and Gelatin at the conclusion of FBS treatment (Scale bar: 20µm). E) 
Quantification of adhered viable cells remaining on coated surfaces after trypsinization reveals 
stronger cell attachment to DCHMM compared to Gelatin (*P-value < 0.01). F) qPCR analysis of neural 
genes in NSPC samples seeded for 48hours on DCHMO, DCHMM, and Gelatin substrates in FBS 
containing medium (n=4, cDNA for each sample derived from mRNA collected by pooling of mRNA 
collected from cells from 3 unique experiments, * P-value < 0.03). Welch's t-tests were applied for the 
comparison of means throughout Figure 7.   
 
 
[Designated as a full page width (two column) figure]  
FIGURE 8 
 
 
Figure 8: NSPC transplanted into healthy mouse brain using DCHMO vehicle display an immature 
glial phenotype at 4 weeks. A) Immunohistochemical analysis of the DCHMO + NSPC injection zone 
demonstrates abundant HA positive transplanted cells that robustly express GFAP and SOX9. B) 
High magnification and three-dimensional orthogonal-image of two unique HA positive cells that have 
integrated into healthy neural tissue and have adopted distinct, individual cellular domains. C) HA 
positive cells maintain robust expression of SOX2. Arrows in C) indicate transplanted neurospheres 
that have adhered to the margins of the DCHMO deposit and integrated into host tissue. D) HA 
positive cells maintain robust expression of NESTIN. Scale bars in: A), C) & D) are 25 µm; B) is 10 
µm.   
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Figure 9: Transplanted NSPC interact with host neurons and provide cellular substrates for 
host axon growth. A) Immunohistochemical image showing integration of HA positive transplanted 
cells into host tissue with abundant NEUN positive neurons. B) High magnification image of a field 
from A) with a three dimensional orthogonal projection depicting HA positive cells interacting with 
NEUN positive neurons via GFAP positive cellular projections. C) Immunohistochemical image 
showing HA positive cells providing a cellular substrate for regrowth of axons that have been 
disrupted as a result of hydrogel injection. The torturous growth projection of the axon stained with 
NFM is indicative of a newly regrowing or sprouted fiber. D) High magnification, three dimensional 
orthogonal projection showing NFM positive regrowing fibers in contact with a HA positive cells.  
Scale bars in: A) is 25 µm; B) & C) are 10 µm; and D) is 5 µm.   
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Figure 10: The progeny of transplanted NSPC do not express markers of mature astrocytes 
at 4 weeks but do interact directly with host mature astrocytes. A) Immunohistochemical image 
of HA positive cells intermingling with host astrocytes (GFAP & ALDH1L1 double positive cells). HA 
positive cells do not express ALDH1L1 and there are discrete regions of GFAP positive cells 
attributed to transplanted cells that do not express ALDH1L1. B) Some, but not all, HA positive cells 
express S100β as observed in the immunohistochemical image. White signal in B) indicates S100β 
and HA staining co-localization. C) High magnification, three dimensional orthogonal projection of HA 
& GFAP double positive transplanted cells interacting with an ALDH1L1 & GFAP double positive host 
astrocyte. In C) yellow staining is indicative of HA and GFAP co-localization while white staining is 
indicative of ALDH1L1 and GFAP co-localization. Scale bars in: A) & B) are 25 µm, C) is 10 µm. 
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